HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NTP peer review

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will hold a meeting June 12 in Triangle Park, N.C. to review findings and conclusions from four draft NTP Technical Reports on rodent toxicology and carcinogenicity studies conducted by NTP, National Institute of Environmental Health Sciences announces in March 9 Federal Register 1notice. Technical reports include document on methylene blue trihydrate, a dye previously used in hair colorants, as well as a report on alpha-methylstyrene, used in the production of resins and polymers. Subcommittee deliberations will be reported to the NTP Board at a future date...

You may also be interested in...



NTP peer review

The National Toxicology Program Board of Scientific Counselors Technical Reports Review Subcommittee will meet Aug. 28 to discuss peer review findings and conclusions presented in five draft NTP technical reports of rodent toxicology and carcinogenicity studies in genetically modified mice, National Institutes of Environmental Health Sciences announces in July 10 Federal Register 1notice. The meeting will begin at 8:30 a.m. at NIEHS in Research Triangle Park, N.C. Technical reports slated for review include document on benzene, which is used in the manufacture of dyes, oils, varnishes and lacquers. Subcommittee most recently met June 12 to review four technical reports on four other ingredients (2"The Rose Sheet" March 13, 2006, In Brief)...

More Top-Level Pharma Changes In India, Cipla Gets CSO

Top-level personnel movement continues at pharma firms in India, with Cipla now appointing an ex-Amneal executive as its Chief Scientific Officer, while Abbott has effected a rejig at the helm.

India Acts To Limit Supply Disruption From Coronavirus

Indian pharmaceutical companies will soon be asked to seek a no objection certificate for the export of 12 APIs and their formulations, as the country deals with Chinese raw material supply disruptions on the back of the coronavirus crisis. However, the move is not expected to impact the export quantum for now.

UsernamePublicRestriction

Register

RS013785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel